(2-Methyl-5-Nitrophenyl)Guanidine Nitrate

We are (2-Methyl-5-Nitrophenyl)Guanidine Nitrate CAS:152460-08-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (2-Methyl-5-Nitrophenyl)Guanidine Nitrate
CAS.NO:   152460-08-7
Synonyms:
1-(2-Methyl-5-nitrophenyl)guanidine Nitrate
2-(2-methyl-5-nitrophenyl)guanidine,nitric acid

Molecular Formula: C8H10N5O5
Molecular Weight:257.203

Physical and Chemical Properties:
Density: /
Boiling point: 426.7ºC at 760 mmHg
Melting point:218-219ºC
Flash point:211.9ºC
Refractive index:/

Specification:
Appearance:Off-white solid
Purity:≥99%
Moisture:≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Imatinib mesylate  CAS: 220127-57-1
Intermediates of Imatinib  CAS:152459-95-5

(2-Methyl-5-Nitrophenyl)Guanidine Nitrate


Related News: Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.2 – ((2-Amino-4-nitrofenil) amino) etanol CAS:56932-44-6 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.2-Amino-5-nitro-4-picoline CAS:21901-40-6 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.phenoxyacetic acid Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.

Related Products
Product Name
(9,9-dimethylfluoren-2-yl)boronic acid View Details
sodium,4-chloro-1-hydroxybutane-1-sulfonate View Details
Trans-4-Isopropylcyclohexane Carboxylic Acid View Details
Hexanedione manufacturer 4-[2-(1-Pipiridine)ethoxybenzoic acid hydrochloride manufacturer 2,2-Difluoroethanol manufacturer 4-Fluoro-3-nitrobenzonitrile manufacturer Antioxidant 412S manufacturer